key: cord-0986228-mgrwnf2s
authors: Guarnieri, Joseph W.; Angelin, Alessia; Murdock, Deborah G.; Portluri, Prasanth; Lie, Timothy; Wallace, Douglas C.
title: SARS-CoV-2 Viroporins Activate The NLRP3-Inflammasome Via The Mitochondrial Permeability Transition Pore
date: 2022-02-22
journal: bioRxiv
DOI: 10.1101/2022.02.19.481139
sha: 4754d0428452e932eeb9f5ad99590465697ffcc6
doc_id: 986228
cord_uid: mgrwnf2s

Cytokine storm precipitated by activation of the host innate immune defenses is a major cause of COVID19 death. To elucidate how SARS-CoV-2 initiates this inflammatory process, we studied viroporin proteins E and Orf3a (2-E+2-3a). Expression of 2-E+2-3a in human 293T cells resulted in increased cytosolic Ca++ and then elevated mitochondrial Ca++, taken up through the MUCi11-sensitive mitochondrial calcium uniporter (MCU). Increased mitochondrial Ca++ resulted in stimulation of mitochondrial reactive oxygen species (mROS) production, which was blocked by mitochondrially-targeted catalase or MnTBAP. To determined how mROS activates the inflammasome, we transformed 293T cells with NLRP3, ASC, pro-caspase-1 and pro-IL-1β plus used THP1 derived macrophages to monitor the secretion of mature IL-1β. This revealed that mROS activates a factor that is released via the NIM811-sensitive mitochondrial permeability pore (mtPTP) to activate the inflammasome. Hence, interventions targeting mROS and the mtPTP may mitigate the severity of COVID19 cytokine storms.

Cytokine storm precipitated by activation of the host innate immune defenses is a major cause of COVID19 19

death. To elucidate how SARS-CoV-2 initiates this inflammatory process, we studied viroporin proteins E and 20

Orf3a (2-E+2-3a). Expression of 2-E+2-3a in human 293T cells resulted in increased cytosolic Ca ++ and then 21 elevated mitochondrial Ca ++ , taken up through the MUCi11-sensitive mitochondrial calcium uniporter (MCU). 22

Increased mitochondrial Ca ++ resulted in stimulation of mitochondrial reactive oxygen species (mROS) 23

production, which was blocked by mitochondrially-targeted catalase or MnTBAP. To determined how mROS 24

activates the inflammasome, we transformed 293T cells with NLRP3, ASC, pro-caspase-1 and pro-IL-1β plus 25 used THP1 derived macrophages to monitor the secretion of mature IL-1β. This revealed that mROS activates 26 a factor that is released via the NIM811-sensitive mitochondrial permeability pore (mtPTP) to activate the 27 inflammasome. Hence, interventions targeting mROS and the mtPTP may mitigate the severity of COVID19 28 cytokine storms.

Keywords: SARS-CoV-2, COVID-19; cytokine storm; NLRP3-inflammasome; ORF3a; envelope (E); viroporin; 31 mitochondrial permeability transition pore; mitochondrial reactive oxygen species (mROS); mitochondria in 32 innate immune responses .  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  INTRODUCTION RESULTS  109  110 Expression of 2-E+2-3a increases Ca ++ leakage into the cytosol, elevates mitochondrial Ca ++ levels, and 111 increases mROS production. 112 We constructed a polycistronic expression vector combining 2-E+2-3a (LV-E3a) ( Figure 1A&B ). In this 113

vector the 2-E+2-3a sequences were separated by the self-cleaving 2A peptide site (Liu et al., 2017; Szymczak-114

Workman et al., 2012) to allow co-expression from a single transcript. The expression of 2-E+2-3a in LV-E3a 115 transduced 293T cells was confirmed by Western blot (Figure 1C) . We next demonstrated that LV-E3a 116 transduced 293T cells experience increased cytosolic Ca ++ with Fura-Red (Figure 1D -F) and mitochondrial Ca ++ 117

with Rhod2 ( Figure 1G-I) . Thapsigargin (TG), which triggers Ca ++ flux into the cytosol, increased mitochondrial 118

Ca ++ uptake (Bagur and Hajnóczky, 2017; Csordás et al., 2018), and mitochondrial Ca ++ uptake was increased 119

in TG treated LV-E3a transduced cells. Co-treatment with the mitochondrial calcium uniporter inhibitor 11 120 (MCUi11) (Di Marco et al., 2020; Márta et al., 2021) abolished mitochondrial calcium uptake ( Figure 1J) . Thus, 121

expression of 2-E+2-3a in 293T cells results in elevated cytosolic Ca ++ which is taken up by the mitochondrial 122 calcium uniporter resulting in elevated mitochondrial Ca ++ (Figure 1J ). 123 We next demonstrated that 2-E+2-3a expression in 293T cells increased mROS production by staining 124

transduced cells with MitoSOX, which detects mitochondrial superoxide anion production. MitoSOX fluorescence 125

confirmed that 2-E+2-3a expression increased mROS production (Figure 1K-M) . To determine if the increased 126 mROS was due to the entry of Ca ++ into the mitochondrion, we treated the cells with MCUi11which blocked the 127 increased mROS production ( Figure 1N ). 128

To confirm that the 2-E+2-3a induced ROS production was mROS, we transformed the 2-E+2-3a 129

expressing 293T cells with a vector expressing mitochondrially-targeted catalase (mCAT) ( secretion.

We then confirmed that 2-E+2-3a expression activates the NLRP3-I and IL-1β secretion via increased 147 mROS production. 293T cells expressing the inflammasome proteins ( Figure 3C ) and LPS-nigericin treated 148 THP1 macrophages ( Figure 3D&E ) were treated with mitochondrially targeted antioxidants, transformation with 149 mCAT or treatment with MnTBAP. Both mCAT expression and MnTBAP treatment impaired IL-1β secretion.

We then determined if mROS activation of the NLRP3-I was mediated by release of an oxidized 151 mitochondrial component via the mtPTP, which has been conjectured but not proven. We treated 2-E+2-3a 152

transformed THP1 macrophages with the specific mtPTP inhibitor N-methyl-4-isoleucine-cyclosporin (NIM811 the mtPTP is the route by which an oxidized mitochondrial factor reaches the NRLP3-I ( Figure 3F ).

Thus, we have demonstrated that co-expression of 2-E+2-3a enhances Ca ++ leakage into the cytosol, 158

increasing levels of cytosolic and mitochondrial Ca ++ . This 2-E+2-3a mediated increase in mitochondrial Ca ++ 159

induces the production of mROS, which in turn activates the NLRP3-I, via mtPTP transport of an oxidized 160 mitochondrial product, stimulating the secretion of IL-1β. Increasing mitochondrial antioxidant defenses through 161 treatment with the pharmacological mROS scavenger MnTBAP, or genetic expression of mCAT, detoxifies 2-162 E+2-3a induced mROS and blocks activation of the NLRP3-I. Together these findings reveal that the mechanism 163 by which 2-E+2-3a engage the NLRP3-I is via viroporin manipulation of mitochondrial physiology. 164 165 DISCUSSION 166 167

Because of the importance that activation of the inflammasome by SARS-CoV-2 has on the severity of 168 COVID19, we set out to define the physiological process by which the virus activates the NLRP3-I in hopes of 169

identifying drug targets to mitigate the cytokine storm. We found that the viroporins 2-E+2-3a were central to the 170 activation of the NLRP3-I and this occurred through a mitochondrial innate immunity signal transduction pathway. 171

Expression of viroporins 2-E+2-3a results in the release of ER and extracellular Ca ++ into the cytosol where the 172

Ca ++ is taken up by the mitochondrion via the mitochondrial calcium uniporter. The mitochondrial Ca ++ activates 173 the tricarboxylic acid cycle dehydrogenases generating excess NADH (Denton, 2009 ). This overloads the 174 electron transport chain producing increased mROS. The increased mROS oxidizes a mitochondrial factor that 175

is released through the mtPTP to bind and activate the NLRP3-I. 176

While our experiments, did not directly identify the mitochondrial factor released through the mtPTP, other 177 recent studies have shown that this factor is oxidized mtDNA which is a ligand of NLRP3-I ( Error bars represent SEM from 3 independent experiments; statistically significant data is indicated with asterisks 251 (* Addgene plasmid # 75134), CASP1 (pcDNA3-N-Flag-Caspase-1, Addgene plasmid # 75128) and pro-IL-1B 285

(pCMV-pro-Il1b-C-Flag, Addgene plasmid # 75131), The use and construction of the NLRP3-I expression 286

plasmids were previously described (Shi et al., 2016). 287

The plasmid vector used to express mitochondrial-targeted catalase (mCAT) and its respective control 288 vector were p-mCAT (VectorBuilder ID VB170403-1078nzg) and p-EV (VectorBuilder ID VB210726-1273jte), 289

vectorbuilder.com. The p-mCAT transgene cassette is transcribed from the 212 nucleotide elongation factor α1 290

"short" (EFS) promoter. The EFS promoter transcribes a polycistronic transcript encoding EGFP (enhanced 291 green fluorescent protein), a self-cleaving 2A peptide site, followed by mCAT, terminated by a simian virus 40 292 (SV40) late polyA sequence. p-EV is identical to the p-mCAT construct, except lacking the mCAT sequence. vector. 300

The lentiviral vector expressing our mCAT and its respective control vector, LV-mCAT (VB210909-301 1242kdf) and LV-EV(mCAT) (VB900122-0484ubz) were constructed and packaged by VectorBuilder. Catalase activity was assessed through cleavage of H2O2 in 293T cell lysates collected twenty-four hours 355

post-transfection with p-mCAT or p-EV, using a Catalysis Activity Kit (Abcam, ab83464).

Western blot analysis. 358

Twenty-four hours post-transduction, cells were washed once with cold PBS and then lysed with 2.5% n-359

Dodecyl-B-D-Maltoside in 20 mM HEPES (pH 7.4), 50 mM βglycerophosphate, 2 mM EGTA, 10% (v/v) glycerol, 360 and 0.01% Bromophenol blue. Lysates were electrophoresed on 4 to 12%, Bis-Tris gels (Invitrogen) SDS-361

polyacrylamide NuPAGE™ gels Gels were ransferred to a nitrocellulose membrane by the iBlot Gel Transfer 362

System (Invitrogen), membranes blocked for one hour in 5% nonfat milk in 25 mM Tris-HCl, 150 mM NaCl, 0.1% 363

Tween 20 (TBST buffer and incubated overnight at 4°C with shaking in primary antibody diluted 1:1000 in TBST.

Membranes were then washed three times with TBST and incubated with Alexa Fluor-conjugated secondary 365 antibodies for one hour at room temperature. Protein levels were quantified using the Odyssey imaging system 366 (LiCOR Biosciences) using. GAPDH as a loading control. MnTBAP. Cell lysates and culture supernatants were collected twelve hours post-treatment andcentrifuged to 375 remove cell debris. Supernatant IL-1β was quantified by ELISA (Abcam, ab197742).

THP-1 cells were plated at a density of 100 × 10 3 in 96-well plates. THP1 cells were infected with LV-EV 377 or LV-E3a. Six hours post-infection, THP1 cells were differentiated into macrophages with 50 ng/ml Phorbol 12-378 myristate 13-acetate (PMA) overnight. After differentiation, cells were washed two times with PBS, and fresh 379 media was added with addition of 100 μM MnTBAP or 10 μM N-methyl-4-isoleucine-cyclosporin (NIM811). Nine 380 hours post-treatment with MnTBAP or one hour post-treatment with NIM811 THP1 macrophages were stimulated 381 with 100 ng/ml Lipopolysaccharides (LPS) and 2.5 mM of nigericin for nine hrousSupernatants were collected, 382

centrifuged, and the amount of supernatants IL-1β measured by ELISA (Abcam, ab46052) . THP1 cells stably 383 expressing LV-mCAT or control vector, were infected with LV-EV or LV-E3a, and 6 hours post-infection the THP1 384 cells were differentiated into macrophages, and supernatant IL-1β quantified via ELISA. 385 386 QUANTIFICATION AND STATISTICAL ANALYSIS 387 388

Statistical analysis 389

One-way ANOVA was performed for statistical differences between three or more groups, followed by a 390 post hoc Tukey's HSD test to test for statistical differences. For studies that require a quantitative evaluation 391 between two groups, statistical significance was determined using unpaired two-tail student's t-test. All data are 392

reported as mean ± standard error of the mean (SEM). All statistical analysis was done on GraphPad Prism 393 9.01. For student's t-test * = p < value 0.05, ** = p < value 0.01, *** = p < value 0.001, **** = p < value 0.0001). ORF3a-mediated incomplete autophagy facilitates severe acute respiratory syndrome coronavirus-2 529

replication. Frontiers in cell and developmental biology 9, 716208. 

The signal pathways and treatment of cytokine 590 storm in COVID-19

SARS-Coronavirus open reading frame-3a drives multimodal necrotic cell death

Suppression of NLRP3 inflammasome, pyroptosis, and cell 596 death by NIM811 in rotenone-exposed cells as an in vitro model of Parkinson's disease

A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication 601 without virulence

New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. 605